Trial Profile
Clinical Research Study of Factor XIII Concentrate From Human Plasma Fibrogammin P in Patients With Factor XIII Deficiency
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2018
Price :
$35
*
At a glance
- Drugs Factor XIII (Primary)
- Indications Congenital disorders; Factor XIII deficiency
- Focus Therapeutic Use
- 10 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Apr 2014 New trial record